Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer.

Molecular cell - 15 Feb 2008

Ghetu Alexandru F, Corcoran Connie M, Cerchietti Leandro, Bardwell Vivian J, Melnick Ari, Privé Gilbert G

Abstract excerpt

The transcriptional corepressors BCOR, SMRT, and NCoR are known to bind competitively to the BCL6 BTB domain despite the fact that BCOR has no detectable sequence similarity to the other two corepressors. We have identified a 17 residue motif from BCOR that binds directly to the BCL6 BTB domain a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Motifs
Share to Crystallography, X-Ray
Share to Dimerization

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histidine

Share to Models, Chemical

Share to Protein Structure, Secondary

Share to Proto-Oncogene Proteins c-bcl-6

Share to Thioredoxins

Source

Open in PubMed Open full text

Identifiers

PMID: 18280243
DOI: 10.1016/j.molcel.2007.12.026
PMCID: PMC2665293

Genes

BCOR
BCL6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18280243-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer.PMID 18280243Read ↗

Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.Semantic proximity Read ↗

Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and BeyondSemantic proximity Read ↗

A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivoSemantic proximity Read ↗

BCL6 as a therapeutic target for lymphoma.Semantic proximity Read ↗

The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.Semantic proximity Read ↗

Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomasSemantic proximity Read ↗

Critical Residues within the BTB Domain of PLZF and Bcl-6 Modulate Interaction with CorepressorsSemantic proximity Read ↗

Peptide molecular glues select between BET paralogues by exploiting allosteric sites and conformational dynamicsSemantic proximity Read ↗

BCOR gene alterations in hematologic diseases.Semantic proximity Read ↗

BRCT Domains: Structure, Functions, and Implications in Disease—New Therapeutic Targets for Innovative Drug Discovery against InfectionsSemantic proximity Read ↗

In-Depth Mutational Analysis of the Promyelocytic Leukemia Zinc Finger BTB/POZ Domain Reveals Motifs and Residues Required for Biological and Transcriptional FunctionsSemantic proximity Read ↗

Discovery of a B-Cell Lymphoma 6 Protein–Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.